Antibodies Against HPV16 Can Develop up to 40 Years Before Throat Cancer is Diagnosed and Mark a 100-fold Increase in Risk in White People
An international group of researchers has found that antibodies to the human papilloma virus type 16 develop in the body between six to 40 years prior to a clinical diagnosis of throat cancer, and their presence indicates a strong increased risk of the disease.